![](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/07/Geopolitical-regulatory-financial-panel.jpg)
Biotech investors remain cautious in a stabilising funding environment
As biotechs pull resources out of thinner budgets, investors are still being cautious with their investments compared to funding highs seen a few years ago. Experts deliberated the regulatory and financial factors influencing the current state of oncology …